Mr. Grigorios Siokas has over 15 years' experience in the pharmaceutical industry. Since 2014, he has served as the CEO and Operations Manager of SkyPharm SA a wholly-owned subsidiary of the Company. SkyPharm SA is a pharmaceutical company located in Greece that mainly exports medicines from Greece to other European countries, such as Germany, England and Denmark.
Prior to 2014, Mr. Siokas worked in a variety of sectors of the pharmaceutical industry mostly in the trading of medicines in Greece and other European countries. Additionally, since 2000 he has been a major shareholder in various pharmaceutical companies such as: Ippokratis Pharmaceuticals, (annual sales of over € 78 million); Thrakis Pharmaceuticals, (annual sales of over € 20 million); Thessalias Pharmaceuticals, (annual sales of over € 18 million); and ZED Pharma SA, (annual sales of over € 35 million).
During the 1990s, Mr. Siokas founded and operated a marble wholesale import – export company in Germany. Within a period of two years he became the 4th biggest Greek marble importer in Germany. He also ran a Tour Operation with many different airlines, serving millions of customers.
Mr. Grigorios Siokas has Bachelor’s Degree in Geology from the Aristotle University of Thessaloniki, Greece. He received a Master’s in management and finance from the University of Stuttgart and the University of Tuebigen, Germany and has served in the Greek Army.
Dimitrios Goulielmos joined us as CEO and Director on September 27, 2013. Since January 1991, he has been the principal attorney at the law firm of Goulielmos D. & Partners. He contributes to the Board the benefits of his legal, academic, and business background.
Mr. Goulielmos is a fourth generation attorney. He received his law degree with Excellency from the Aristotle University of Thessaloniki in 1988. He did post graduate studies for International transactions and Company law at Paris, France and at the LSE of London, England.
In 2004 he was elected Vice-president of EUROPECHE, the organization that was established by the European Committee for the consultation and proposal of solutions in the sector of Community Fishery.
The same year he was also elected as National representative of Hellas in the MEDISAMAK, the organization responsible for all Mediterranean countries, in the sector of Fishery.
In year 2007 he was re-elected as Vice-president of EUROPECHE. He is a member of the social dialogue group of ACFA, of EU on labor affairs.
He is an honorary lifetime member of International Who's Who Historical Society.
Mr. Goulielmos has extensive experience in law, international deals, mergers, acquisitions, negotiations, international application of licenses, and real estate management which he will contribute to the Board.
Mr. Demetrios G. Demetriades was elected as Secretary and Director of the Company.
Since January 2003, Mr. Demetriades, age 48, has been Director of Highlander Spring Trading Ltd, a trading company.
From November 2000 to December 2002 he was Marketing Director of Eurolink Securities Ltd which was involved in trading in the Cyprus Stock Exchange.
From January 1995 to November 2000 he was Supervising Officer of Laiki Factors Ltd, a financing company.
As a member of the board, Mr. Demetriades contributes the benefits of his trading, executive leadership and management experience.
On November 18, 2016, the Board of Directors of Company appointed John J. Hoidas as a member of the Board of Directors. Mr. Hoidas is a registered broker dealer. Mr. Hoidas has served as a broker for the following firms during the corresponding periods.
09/2013 - Present UHLMANN INVESTMENT MANAGEMENT
09/2013 - Present UHLMANN PRICE SECURITIES, LLC
08/2008 - Present BREWER INVESTMENT GROUP CHICAGO, IL
11/2010 - 09/2013 KINGSBURY CAPITAL INVESTMENT ADVISORS
11/2010 - 09/2013 KINGSBURY CAPITAL LLC
11/2010 - 09/2013 SPENCER TRASK VENTURES
John J. Hoidas began working on the floor of the CME in 1989 as a runner and by 1995 started trading the S&P 500 and GSCI Index Futures for 9 years. He then moved to Wealth Management starting with American Express Financial Advisors which spun off to Ameriprise. He then moved to Kingsbury Capital in 2010 & began raising money for late stage pre-IPO companies such as Organovo (ONVO), Invivo Therapeutics (NVIV) and Matinas BioPharma (MTNB) to name a few. Currently John is the senior Vice President at Uhlmann Price, a firm he joined back in 2013. Since he joined Uhlmann Price Securities, he has raised capital for startups such as Video Gaming Co; Gazillion, Inc., Liquidspace, and Revel Systems.